Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial
Amit Saraf, Rohan Gurjar, Swarnendu Kaviraj, et al.
Nature Medicine (2024) Vol. 30, Iss. 5, pp. 1363-1372
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers
Christian J. Maine, Shigeki J. Miyake-Stoner, Darina Spasova, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3
A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus
Min Lin, Yifan Yin, Xiaomeng Zhao, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Advances in the design and delivery of RNA vaccines for infectious diseases
Abhijeet Lokras, Thomas Rønnemoes Bobak, Saahil Baghel, et al.
Advanced Drug Delivery Reviews (2024) Vol. 213, pp. 115419-115419
Open Access | Times Cited: 11
Advanced technologies for the development of infectious disease vaccines
Akash Gupta, Arnab Rudra, Kaelan Reed, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 12, pp. 914-938
Closed Access | Times Cited: 10
Transformative Approaches in SARS-CoV-2 Management: Vaccines, Therapeutics and Future Direction
Ankita Saha, Shweta Choudhary, Priyanshu Walia, et al.
Virology (2025) Vol. 604, pp. 110394-110394
Closed Access | Times Cited: 1
Clade 2.3.4.4b but not historical clade 1 HA replicating RNA vaccine protects against bovine H5N1 challenge in mice
David W. Hawman, Thomas Tipih, Edgar A. Hodge, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Natural, modified and conjugated carbohydrates in nucleic acids
Debashis Dhara, Laurence A. Mulard, Marcel Hollenstein
Chemical Society Reviews (2025)
Open Access | Times Cited: 1
Cellular immune breadth of an Omicron-specific, self-amplifying monovalent mRNA vaccine booster for COVID-19
Durgesh Kumar, Kishor Gaikwad, Rushank Gunnale, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
AI-Driven Resilience Strategies for Enhancing Healthcare Supply Chain Resilience: A Systematic Literature Review (Preprint)
Parvez Ahmed, Adnan Muhammad Shah, Kang Yoon Lee
(2025)
Closed Access
Transfection via RNA-Based Nanoparticles: Comparing Encapsulation vs Adsorption Approaches of RNA Incorporation
Amy E. Laturski, Maria T. Dulay, Jillian L. Perry, et al.
Bioconjugate Chemistry (2025)
Closed Access
What Is Next for COVID-19 Vaccination?
Antoni Trilla, Guillem Trilla, Marta Aldea, et al.
Seminars in Respiratory and Critical Care Medicine (2025)
Closed Access
Broad-spectrum immune suppression encoded in self-amplifying RNA enables non-cytotoxic, non-immunostimulatory, externally controllable transgene expression
Tony K.Y. Lim, Anne Ritoux, Luke W Paine, et al.
(2025)
Open Access
Broad-spectrum immune suppression encoded in self-amplifying RNA enables non-cytotoxic, non-immunostimulatory, externally controllable transgene expression
Tony K.Y. Lim, Anne Ritoux, Luke W Paine, et al.
(2025)
Open Access
Safety profile of self-amplifying mRNA SARS-CoV-2 vaccine ARCT-154 in adults: a pooled phase 1/2/3 randomized clinical study
Nhan Thi Ho, Igor Smolenov, Lydia Tran, et al.
Expert Review of Vaccines (2025)
Open Access
Nanotheranostics Revolutionizing Gene Therapy: Emerging Applications in Gene Delivery Enhancement
Paula Guzmán-Sastoque, Cristian F. Rodríguez, María Camila Monsalve, et al.
Journal of Nanotheranostics (2025) Vol. 6, Iss. 2, pp. 10-10
Open Access
Self-Amplifying RNA: Advantages and Challenges of a Versatile Platform for Vaccine Development
Thomas Vallet, Marco Vignuzzi
Viruses (2025) Vol. 17, Iss. 4, pp. 566-566
Open Access
Beyond the Pandemic Era: Recent Advances and Efficacy of SARS-CoV-2 Vaccines Against Emerging Variants of Concern
Ankita Saha, Sounak Ghosh Roy, Richa Dwivedi, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 424-424
Open Access
Immunogenicity of a booster dose of a bivalent (Asp614Gly and omicron BA.4/5 variant) self-amplifying mRNA SARS-CoV-2 booster vaccine versus the BNT162b2 omicron BA.4/5 mRNA vaccine: a randomised phase 3 trial
Yusuke Okada, Yuji Kumagai, Iori Okura, et al.
The Lancet Infectious Diseases (2024)
Closed Access | Times Cited: 2
Preclinical development of lyophilized self-replicating RNA vaccines for COVID-19 and malaria with improved long-term thermostability
Gaurav Kumar Gulati, Adrian Simpson, Zachary MacMillen, et al.
Journal of Controlled Release (2024) Vol. 377, pp. 81-92
Closed Access | Times Cited: 2
Immunogenicity and protection efficacy of self-amplifying and circular mRNA vaccines for SARS-CoV-2
Oinam Ningthemmani Singh, Umang Berry, Garima Joshi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Non-immunogenic and reversible transgene expression using self-amplifying RNA
Tony K.Y. Lim, Anne Ritoux, Luke W Paine, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Vaccine Research and Development in India for COVID-19 and Influenza
Kawkab Kanjo, Chakshusmathi Ghadiyaram, Raghavan Varadarajan
(2024), pp. 147-173
Closed Access
Steps towards licensure of self-amplifying RNA vaccines
M. Wilbrink, Sander Herfst, Rory D. de Vries
The Lancet Infectious Diseases (2024)
Closed Access
Development of Self‐Adjuvants in mRNA Vaccine and Its Application in Disease Prevention and Treatment
Huaibin Yu, Yafang Lu, Zhi‐Feng Miao, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 6
Open Access
Session 4: mRNA and Self-Amplifying RNA (saRNA): Opportunities for Disease Prevention and Therapy
Rani S. Sellers, Lila Ramaiah, Sue‐Jean Hong, et al.
Toxicologic Pathology (2024)
Closed Access
Page 1 - Next Page

Scroll to top